అకౌంట్స్ గమనికలుMahamaya Lifesciences Ltd.

Mar 31, 2025

o) Provisions

A provision is recognized when the Company has a present obligation as a result of past event, it is
probable that an outflow of resources embodying economic benefits will be required to settle the obligation
and a reliable estimate can be made of the amount of the obligation. Provisions are not discounted to their
present value and are determined based on the best estimate required to settle the obligation at the reporting
date. These estimates are reviewed at each reporting date and adjusted to reflect the current best estimates.
The expense relating to any provision is presented in the statement of profit and loss, net of any
reimbursement.

p) Contingent Liabilities

A Contingent Liability is a possible obligation that arises from past events whose existence will be
confirmed by the occurrence or non-occurrence of one or more uncertain future events beyond the control
of the company or a present obligation that is not recognized because it is not probable that an outflow of
resources will be required to settle the obligation. A contingent liability also arises in extremely rare cases
where there is a liability that cannot be recognized because it cannot be measured reliably. The Company
does not recognize a contingent liability but discloses its existence in the financial statements.

q) Cash and Cash Equivalents

Cash and cash equivalents comprises Cash-in-hand, Current Accounts, Fixed Deposits with banks.
Cash equivalents are short-term balances (with an original maturity of three months or less from the
date of acquisition), highly liquid investments that are readily convertible into known amounts of
cash and which are subject to insignificant risk of changes in value. Other Bank Balances are
short-term balance (with original maturity is more than three months but less than twelve months).

32. Related Party Transactions

The Company has identified the following persons as Related Parties and the nature of relationship
with them is as follows:

Name of Related Parties and Relationship:

Key Management Personnel

- Mr. Krishnamurthy Ganesan - Managing Director

- Mrs. Lalitha Krishnamurthy - Whole-time Director

- Mr. Prashant Krishnamurthy - Executive Director & Chief Financial Officer (CFO)

Wholly Owned Subsidiary Companies

- Mahamaya Lifesciences FZE (incorporated on 5^th April,2017)

(See Note no: 12 - Non-Current Investments for details)

Entities over which Key Management Personnel have significant influence

- Chemlinks India

- Clearship Travels & Tours Pvt Ltd

33. Leases

The company is having office on operating lease at Gurgaon, Haryana with lock in period of 2 years. The
company is also having godown facilities on rent at multiple locations.

Lease payment charged during the period to the statement of profit and loss amounts to Rs. 10.56 lacs
(March 31, 2024: Rs.10.64 lacs)

There are no Future lease payments payable under above lease during non-cancellable period

34. The government of India has promulgated an Act namely the Micro, and Small Enterprises as per
MSMED Act, 2006 which comes into force with effect from October 2, 2006. As per the Act, the
Company is required to identify the Micro, Small and Medium suppliers and pay them interest on
overdue beyond the specified period irrespective of the terms agreed with suppliers.

39. Segment Reporting

The Company has evaluated the applicability of segment reporting and has concluded that the Company
has only one Primary Business Segment i.e., Agrochemicals and One Geographical reportable segment
i.e. Operations mainly within India. The overall performance is reviewed by the Board of Directors.
Thus, the segment revenue, expenses, results, assets and liabilities are same as reflected in the financial
statements as at and for the year ended 31st March 2025.

40. The Company has filed DRHP in the BSE SME PLATFORM ON 27TH FEBRUARY 2025, for the
purpose of Initial Public Offering and the application is under process. As part of the DRHP filing, the
Financial Statements were restated for the last 3 years (21-22, 22-23 & 23-24) to match with the SEBI
ICDR regulations. The changes made to the last 3 years'' financials have been given effect in the books of
accounts in these financials as prior period adjustments in the Profit and Loss account and in the Balance
Sheet against the relevant Asset/ Liability to reflect the restated figures.

41. Previous year''s figures have been regrouped where necessary to confirm to this year''s classification.
As per our report of even date

For N Naresh & Co For and on behalf of board of directors of

Chartered Accountants Mahamaya Lifesciences Limited

Firm Registration no: 011293S

Sd/- Sd/- Sd/-

CA Kumar E Krishnamurthy Lalitha

Partner Ganesan Krishnamurthy

Membership No. : 217549 Managing Whole-time

Director Director

DIN:00270539 DIN: 00425675

Place : New Delhi Sd/- Sd/-

Date : 14-06-2025

Prashant Shilpi Bhardwaj

Krishnamurthy Company Secretary

Chief Financial Membership No. : A24444

Officer